Published in Transplant Proc on June 01, 2001
Predisposition to familial osteoarthrosis linked to type II collagen gene. Lancet (1989) 2.43
Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol (1987) 2.41
Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol (1994) 2.12
A standardized experimental fracture in the mouse tibia. J Orthop Res (1993) 1.75
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim Biophys Acta (1991) 1.67
Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J Biol Chem (1991) 1.67
Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem (1996) 1.60
Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol (2001) 1.55
CHEK2 variants associate with hereditary prostate cancer. Br J Cancer (2003) 1.54
Alloimmune injury preceding airway obliteration in porcine heterotopic lung implants: a histologic and immunohistologic study. Transplantation (1999) 1.44
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn (1997) 1.44
Newer immunosuppressive drugs: a review. J Am Soc Nephrol (1999) 1.43
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A (1991) 1.37
Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage. Nucleic Acids Res (1982) 1.35
Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res (1987) 1.35
The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem J (1993) 1.28
Normal long bone growth and development in type X collagen-null mice. Nat Genet (1994) 1.26
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res (2001) 1.26
Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta (1987) 1.25
Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development (1988) 1.25
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol (1988) 1.21
A metaphyseal defect model of the femur for studies of murine bone healing. Bone (2001) 1.19
Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett (1996) 1.18
Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol (1992) 1.16
Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-fos genes in developing human calvarial bones. Dev Biol (1988) 1.15
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
Construction of a human pro alpha 1(III) collagen cDNA clone and localization of type III collagen expression in human fetal tissues. Matrix (1989) 1.08
Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice. Dev Dyn (1995) 1.06
Role of cathepsin K in normal joints and in the development of arthritis. Curr Drug Targets (2007) 1.06
Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res (2001) 1.05
Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol Endocrinol (1993) 1.05
Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol (1991) 1.05
Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res (1988) 1.04
Localization of type I and III collagen and fibronectin production in injured gastrocnemius muscle. Lab Invest (1991) 1.04
Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2001) 1.03
Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice. Proc Natl Acad Sci U S A (1993) 1.02
Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res (1997) 1.01
Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta (1984) 1.01
Identification of messenger RNA for human type II collagen. FEBS Lett (1984) 1.01
Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim Biophys Acta (1994) 1.01
Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur J Cancer (2000) 1.00
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2000) 0.99
Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer (1994) 0.98
Indications for and risks in reoperation for coronary artery disease. Scand J Thorac Cardiovasc Surg (1990) 0.98
Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett (1989) 0.96
Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int (1982) 0.96
Conservation of the sizes of 53 introns and over 100 intronic sequences for the binding of common transcription factors in the human and mouse genes for type II procollagen (COL2A1). Biochem J (1995) 0.96
Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene (1990) 0.95
Cathepsin expression during skeletal development. Biochim Biophys Acta (1999) 0.95
Determination of the single polyadenylation site of the human pro alpha 1(II) collagen gene. Nucleic Acids Res (1987) 0.95
Regulation of extracellular matrix genes during fracture healing in mice. Clin Orthop Relat Res (1993) 0.94
Structural analysis of the regulatory elements of the type-II procollagen gene. Conservation of promoter and first intron sequences between human and mouse. Biochem J (1992) 0.94
Coordinate patterns of expression of type I and III collagens during mouse development. Matrix Biol (1995) 0.94
Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett (1987) 0.93
Activation of type I collagen genes in cultured scleroderma fibroblasts. J Cell Biochem (1985) 0.93
Expression of mRNAs coding for the alpha 1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II, and III. J Cell Biol (1989) 0.93
Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg (2000) 0.93
Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int (2000) 0.93
Capturing dynamics with Eiger, a fast-framing X-ray detector. J Synchrotron Radiat (2012) 0.92
In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus. J Bone Joint Surg Am (1989) 0.92
Type X collagen, a natural component of mouse articular cartilage: association with growth, aging, and osteoarthritis. Arthritis Rheum (1998) 0.92
Lifelong voluntary joint loading increases osteoarthritis in mice housing a deletion mutation in type II procollagen gene, and slightly also in non-transgenic mice. Ann Rheum Dis (2002) 0.92
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS (2001) 0.92
Autoimmune recognition of cartilage collagens. Ann Med (1993) 0.91
Evidence for insufficient chondrocytic differentiation during repair of full-thickness defects of articular cartilage. Matrix Biol (1996) 0.91
Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG). Int J Legal Med (1999) 0.91
Construction and identification of a cDNA clone for human type II procollagen mRNA. Biochem J (1985) 0.91
Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem J (1987) 0.90
Age-dependent changes in the expression of matrix components in the mouse eye. Exp Eye Res (2001) 0.90
Growth-dependent modulation of type I collagen production and mRNA levels in cultured human skin fibroblasts. Biochim Biophys Acta (1990) 0.90
Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model. J Bone Miner Res (1999) 0.90
Comparison on collagen gene expression in the developing chick embryo tendon and heart. Tissue and development time-dependent action of dexamethasone. Biochim Biophys Acta (1991) 0.90
Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol (1991) 0.89
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. J Med Genet (2006) 0.89
Type I collagen messenger RNA levels in experimental granulation tissue and silicosis in rats. Med Biol (1986) 0.89
The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett (1997) 0.89
The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. J Cell Biol (1989) 0.89
Differential expression of fibrillar collagen genes during callus formation. Biochem Biophys Res Commun (1987) 0.88
Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy. J Heart Lung Transplant (1994) 0.87
Characterization of recombinant human type IX collagen. Association of alpha chains into homotrimeric and heterotrimeric molecules. J Biol Chem (1999) 0.87
Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis. Scand J Gastroenterol (1997) 0.87
Identification of germline MLH1 alterations in familial prostate cancer. Eur J Cancer (2006) 0.87
Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection. Pulm Pharmacol Ther (2002) 0.87
Polymorphic restriction sites of type II collagen gene: their location and frequencies in the Finnish population. Hum Hered (1988) 0.87
Indicators for comparing the incidence of diabetic amputations: a nationwide population-based register study. Eur J Vasc Endovasc Surg (2013) 0.86
Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J Bone Miner Res (2001) 0.86
Localization of osteonectin expression in human fetal skeletal tissues by in situ hybridization. Calcif Tissue Int (1989) 0.86
Thrombosed coronary artery fistula as a cause of paroxysmal atrial fibrillation and ventricular arrhythmia. Cardiovasc Surg (1994) 0.85
Effect of physical training on exercise capacity and gas exchange in patients with chronic heart failure. Chest (1996) 0.85
The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transpl Infect Dis (1999) 0.85
Specific hybridization probes for mouse alpha 2(IX) and alpha 1(X) collagen mRNAs. Biochim Biophys Acta (1992) 0.85
Cysteine proteinases in chondrosarcomas. Matrix Biol (2001) 0.85
Abnormal craniofacial morphology and cartilage structure in transgenic mice harboring a Gly --> Cys mutation in the cartilage-specific type II collagen gene. J Craniofac Genet Dev Biol (1993) 0.85
Ultrasonography as a differential diagnostic aid in achillodynia. J Ultrasound Med (1987) 0.85
Synthesis of laminin and type IV collagen by trophoblastic cells and fibroblastic stromal cells in the early human placenta. Lab Invest (1991) 0.85
Combined effect of BMP-2 gene transfer and bioactive glass microspheres on enhancement of new bone formation. J Biomed Mater Res A (2005) 0.84